论文部分内容阅读
目的:探讨分析胺碘酮治疗心衰合并心律失常的临床疗效。方法:选择112例心衰合并心律失常的患者,随机分为56例对照组和56例实验组,对照组采用常规治疗,实验组在对照组患者治疗的基础上加用胺碘酮。结果:经治疗后,实验组和对照组的心率均显著降低,DBP、SBP、LVEF和FS明显升高;而实验组的上述指标均显著优于对照组。结结论:论胺碘酮治疗心衰合并心律失常的疗效显著,不良反应小,值得临床推广。
Objective: To investigate the clinical efficacy of amiodarone in the treatment of heart failure with arrhythmia. Methods: One hundred and twelve patients with heart failure and arrhythmia were randomly divided into 56 control groups and 56 experimental groups. The control group was treated with conventional therapy. The experimental group was given amiodarone on the basis of the treatment of the control group. Results: After treatment, the heart rate of experimental group and control group were significantly decreased, DBP, SBP, LVEF and FS were significantly increased; while the experimental group of the above indicators were significantly better than the control group. Conclusion: Amiodarone treatment of heart failure complicated with arrhythmia significant effect, small adverse reactions, it is worth clinical promotion.